NCT07774819
- Conditions
- Radiotherapy-Induced Immune Priming
- Locations
-
- The University of Hong Kong - Shenzhen Hospital Shenzhen, Guangdong, China
Clinical trial condition
Radiotherapy-Induced Immune Priming
Explore clinical trials studying Radiotherapy-Induced Immune Priming. Study availability and eligibility vary by location and protocol.
3 public trials
2 recruiting studies
Radiotherapy-Induced Immune Priming trial results
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Elranatamab, +19 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Not yet recruiting
Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study
NCT07467590
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
- Locations
-
Not specified